Real-time enrollment status for this pulmonary fibrosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT06238622 |
| Recruiting Status | Recruiting |
| Condition | Pulmonary Fibrosis |
| Phase | Clinical Trial |
| Target Enrollment | 1,700 participants |
| Active Locations | 57 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | February 24, 2026 (6 days ago) |
As of March 2, 2026: Clinical trial NCT06238622 is currently recruiting participants. This clinical trial study for pulmonary fibrosis is actively seeking new participants at 57 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06238622 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 57 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06238622 was last updated 6 days ago (February 24, 2026). HelloStudys verifies this status automatically.